Get started
HUA MEDICINEHUA MEDICINEHUA MEDICINE

HUA MEDICINE

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

2552 chart

Key stats

Market capitalization
‪1.45 B‬HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.24HKD
Net income
‪−233.41 M‬HKD
Revenue
‪84.65 M‬HKD
Shares float
‪934.83 M‬
Beta (1Y)
0.52

About HUA MEDICINE

Sector
Health Technology
CEO
Li Chen
Headquarters
Shanghai
Website
huamedicine.com
Employees (FY)
177
Founded
2009
ISIN
KYG4644K1022
FIGI
BBG00LVHG0W8
Hua Medicine Ltd. provides drug discovery and development services. It offers drugs for diabetes and Central Nervous System disorders. Its products include Dorzagliatin HMS552, Dorzagliatin+Metformin, Dorzagliatin+DPPIV, Dorzagliatin+SGLT-2, Dorzagliatin+Insulin, Dorzagliatin+GLP-1 and mGLUR5 NAM. The company was founded by Chen Li on November 10, 2009 and is headquartered in Shanghai, China.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 2552 is 1.51 HKD — it has increased by 1.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange HUA MEDICINE stocks are traded under the ticker 2552.
HUA MEDICINE is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
2552 earnings for the last quarter are −0.11 HKD whereas the estimation was 0.24 HKD which accounts for −147.34% surprise. Estimated earnings for the next quarter are 0.38 HKD. See more details about HUA MEDICINE earnings.
HUA MEDICINE revenue for the last quarter amounts to ‪20.09 M‬ HKD despite the estimated figure of ‪575.56 M‬ HKD. In the next quarter revenue is expected to reach ‪631.09 M‬ HKD.
Yes, you can track HUA MEDICINE financials in yearly and quarterly reports right on TradingView.
Like other stocks, 2552 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUA MEDICINE stock right from TradingView charts — choose your broker and connect to your account.
2552 reached its all-time high on Aug 17, 2020 with the price of 9.00 HKD, and its all-time low was 1.29 HKD and was reached on Apr 2, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 177.00 employees. See our rating of the largest employees — is HUA MEDICINE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUA MEDICINE EBITDA is ‪−331.95 M‬ HKD, and current EBITDA margin is −393.98%. See more stats in HUA MEDICINE financial statements.